Novel metastatic burden‐stratified risk model in de novo metastatic hormone‐sensitive prostate cancer
Masaki Shiota(Kyushu University), Toshiyuki Kamoto(Kyoto University), Takuma Kato(Kagawa University), Yasuhiro Hashimoto(Hirosaki University), Kentaro Kuroiwa(Miyazaki Prefectural Hospital), Shinichi Sakamoto(Chiba University), Toru Shimazui(University of Tsukuba), Ken‐ichi Tabata(Kitasato University), Sadafumi Kawamura(Miyagi Prefectural Hospital Organization), Takashi Mizowaki(Kyoto University), Naoki Kohei(Shizuoka General Hospital), Naoki Terada(Kyoto University), Akira Yokomizo(Kyushu University), Shogo Teraoka(Tottori University Hospital), Hideki Enokida(Kagoshima University Hospital), Hiroaki Matsumoto(Yamaguchi University), Takahiro Kojima(Aichi Cancer Center), Shintaro Narita(Akita University), Masashi Kato(Nagoya University), Yoshiyuki Nagumo(University of Tsukuba Hospital), Koji Mitsuzuka(Pacific Northwest Diabetes Research Institute), Takahiro Inoue(Mie University), Ryotaro Tomida(Shikoku Cancer Center), Hiroyuki Nishiyama(University of Tsukuba), Nobumichi Tanaka(Nara Medical University), Takahiro Osawa(Hokkaido University), Mikio Sugimoto(Kagawa University), Kohei Hashimoto(Sapporo Medical University), Takahiro Kimura(Jikei University School of Medicine), Toshihiro Saito, Toshihiko Sakurai(Sojo University), Takayuki Goto(Kyoto University), Atsushi Takahashi(Fukushima Medical University), Hiroaki Yasumoto(Shimane University), Hiroshi Kitamura(University of Toyama), Manabu Kamiyama(University of Yamanashi Hospital), Masatoshi Eto(Kyushu University), Takayuki Sugiyama(Hamamatsu University)
Cited by 15
Related Papers
Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations
|Nature Genetics|2015|2.8k
SNPs in KCNQ1 are associated with susceptibility to type 2 diabetes in East Asian and European populations
|Nature Genetics|2008|728
Comparative genetic architectures of schizophrenia in East Asian and European populations
|Nature Genetics|2019|709
ctDNA guiding adjuvant immunotherapy in urothelial carcinoma
|Nature|2021|603